含乙酰氧肟酸配体的席夫碱钒配合物的合成、结构及其抑制幽门螺旋杆菌脲酶研究(英文)

本文合成了2个新的含乙酰氧肟酸配体的席夫碱钒配合物,[VⅢL1(HAHA)](1)和[VⅤOL2(AHA)](2),其中L1为N,N′-二(5-甲基水杨基)乙烷-1,2-二胺的二价阴离子,L2为2-{[2-(2-羟乙基氨基)乙亚胺基]甲基}-6-甲基苯酚的一价阴离子,HAHA和AHA分别为乙酰氧肟酸的一价和二价阴离子,通过物理-化学方法以及单晶X-射线衍射表征了它们的结构。在每个化合物中,V原子都采取八面体配位构型。本文还研究了配合物的热稳定性以及其对幽门螺旋杆菌脲酶的抑制活性。在浓度为100μmol·L-1时,配合物1和2对脲酶的抑制率分别为37.2%和81.5%,其中配合物2的IC50值为21.5μmol·L-1。分子对接研究表明配合物2与脲酶活性中心存在有效的作用力。     

酰腙氧钒(Ⅴ)配合物的合成、结构及其抑制幽门螺旋杆菌脲酶研究

本文合成了2个新的结构类似的酰腙氧钒(Ⅴ)配合物,[VOL(OCH3)(CH3OH)](L=L1=2-氯-N′-(5-氯-2-羟基苯亚甲基)苯甲酰肼(1);L=L2=2-氯-N′-(2-羟基-3-甲氧基苯亚甲基)苯甲酰肼(2)),并通过物理化学方法和单晶X-射线衍射表征了它们的结构。在每个配合物中,V原子都采取八面体配位构型,利用配体L中的3个给体原子和1个甲氧配体的氧原子定义其赤道面,利用1个酮氧原子和1个甲醇氧原子占据其2个轴向位置。本文还研究了这2个配合物对幽门螺旋杆菌脲酶的抑制活性。在浓度为100μmol.L-1时,配合物1和2对脲酶的抑制率分别为(82.0%±2.8%)和(28.2%±1.7%)。此外,还做了配合物和幽门螺旋杆菌脲酶的分子对接研究。     

N'-(2-羟基-5-甲氧基苯甲基)-4-二甲氨基苯甲酰肼及其氧钒(V)配合物:合成、晶体结构和脲酶抑制活性

制备了一个苯甲酰腙化合物N'-(2-羟基-5-甲氧基苯甲基)-4-二甲氨基苯甲酰肼(H₂L).利用H₂L、乙酰氧肟酸(HAHA)和VO(acac)₂在甲醇中反应得到了配合物[VOL(AHA)].通过元素分析、红外和紫外光谱,以及单晶X-射线衍射对H₂L和其配合物进行了表征。苯甲酰腙配体作为二价阴离子,利用其酚羟基氧原子、亚胺基氮原子、以及烯醇氧原子与V原子进行配位.乙酰氧肟酸配体利用其羰基氧原子和去质子化的羟基氧原子进行配位.配合物中的V原子为八面体配位构型。测试了H₂L、HAHA和钒配合物的脲酶抑制活性.在浓度为100 μmol·L^-1时,钒配合物对幽门螺旋杆菌脲酶的抑制率为63%,其IC₅₀值为45μmol·L^-1.还利用分子对接技术研究了配合物分子与脲酶的作用方式.     

N'-(2-羟基-5-甲氧基苯甲基)-4-二甲氨基苯甲酰肼及其氧钒(Ⅴ)配合物:合成、晶体结构和脲酶抑制活性

制备了一个苯甲酰腙化合物N'-(2-羟基-5-甲氧基苯甲基)-4-二甲氨基苯甲酰肼(H₂L)。利用H₂L、乙酰氧肟酸(HAHA)和VO(acac)₂在甲醇中反应得到了配合物[VOL(AHA)]。通过元素分析、红外和紫外光谱,以及单晶X-射线衍射对H₂L和其配合物进行了表征。苯甲酰腙配体作为二价阴离子,利用其酚羟基氧原子、亚胺基氮原子、以及烯醇氧原子与V原子进行配位。乙酰氧肟酸配体利用其羰基氧原子和去质子化的羟基氧原子进行配位。配合物中的V原子为八面体配位构型。测试了H₂L、HAHA和钒配合物的脲酶抑制活性。在浓度为100μmol·L^-1时,钒配合物对幽门螺旋杆菌脲酶的抑制率为63%,其IC₅₀值为45μmol·L^-1。还利用分子对接技术研究了配合物分子与脲酶的作用方式。     

酰腙氧钒(Ⅴ)配合物的合成、结构及其抑制幽门螺旋杆菌脲酶研究

为了探索新型高效脲酶抑制剂,本文合成了2个新的酰腙氧钒(V)配合物,[VOL1(OCH3)(CH3OH)](1)和[VOL2(μ-OCH3)]2(2)(H2L1=N′-(5-氯-2-羟基苯亚甲基)-3-硝基苯甲酰肼;H2L2=N′-(5-氯-2-羟基苯亚甲基)-4-氯苯甲酰肼),并通过物理化学方法和单晶X-射线衍射表征了它们的结构。化合物1是一个单核配合物,而化合物2是由两个甲氧基配体桥连的具有中心对称性的双核配合物。在每个配合物中,V原子都采取八面体配位构型。本文还研究了这两个配合物的热稳定性和它们对幽门螺旋杆菌脲酶的抑制活性。在浓度为100μmol.L-1时,配合物1和2对脲酶的抑制率分别为71.4%和73.3%,其IC50值分别为63.6和37.7μmol.L-1。     

基于双席夫碱配体的两个锰(III)配合物的合成、晶体结构和抑制脲酶活性

制备了一个双席夫碱N,N′-双(3,5-二氟亚水杨基)-1,3-二氨基丙烷(H_2L)。利用H_2L、醋酸锰和硫氰酸铵或者叠氮化钠在甲醇中反应分别制得了配合物[MnL(NCS)(OH_2)](1)和[MnL(μ_(1,3)-N_3)]_n(2)。通过元素分析、红外光谱、核磁共振氢谱对H_2L和其配合物进行了表征,用单晶X射线衍射测定了配合物的结构。席夫碱配体利用其亚胺基氮原子和酚羟基氧原子与Mn进行配位。硫氰酸根配体利用其氮原子配位,而叠氮根配体利用两端的氮原子以桥联的方式进行配位。在每个配合物中,Mn原子都采取八面体配位构型。测试了H_2L和2个配合物对刀豆脲酶的抑制活性。在浓度为100μmol·L~(-1)时,配合物1对脲酶的抑制率为(52.0±3.1)%,其IC50值为(81.0±3.7)μmol·L~(-1),而配合物2却没有活性。还利用分子对接技术研究了配合物1与脲酶的作用方式。     

二个含水杨酰腙配体的钒配合物的合成与晶体结构研究

2种水杨酰腙配体H2L1(H2L1=邻羟基苯乙酮缩水杨酰腙)和H2L2(H2L2=水杨醛缩水杨酰腙)分别与VO(acac)2反应,合成了2个钒配合物[VOL1(C2H5O)]2(1)和[VOL2(i-C3H7O)](2),利用元素分析、红外光谱、紫外光谱和单晶衍射等手段进行表征。配合物1是由酚氧原子桥联2个金属中心形成的具有晶体学中心对称性的双核钒(V)配合物结构,每个V(V)原子具有扭曲的八面体配位构型。配合物2为单核结构,每个V(V)原子具有扭曲的四角锥配位构型,相邻的配合物分子通过分子间氢键作用形成一维超分子链状结构。采用循环伏安法研究了化合物2的电化学性质。     

含乙酰氧肟酸配体的席夫碱钒配合物的合成、结构及其抑制幽门螺旋杆菌脲酶研究

本文合成了2个新的含乙酰氧肟酸配体的席夫碱钒配合物,[V^ⅢL¹(HAHA)](1)和[V^ⅤOL²(AHA)](2),其中L¹为N,N’-二(5-甲基水杨基)乙烷-1,2-二胺的二价阴离子,L²为2-{[2-(2-羟乙基氨基)乙亚胺基]甲基}-6-甲基苯酚的一价阴离子,HAHA和AHA分别为乙酰氧肟酸的一价和二价阴离子,通过物理-化学方法以及单晶X-射线衍射表征了它们的结构。在每个化合物中,V原子都采取八面体配位构型。本文还研究了配合物的热稳定性以及其对幽门螺旋杆菌脲酶的抑制活性。在浓度为100μmol·L^-1时,配合物1和2对脲酶的抑制率分别为37.2%和81.5%,其中配合物2的IC₅₀值为21.5μmol·L^-1。分子对接研究表明配合物2与脲酶活性中心存在有效的作用力。     

两个哒嗪衍生物为配体的铜(Ⅱ)配合物的合成、晶体结构和清除自由基活性

本文合成了2个新型Cu(Ⅱ)配合物:[Cu2(L1)2Cl4]L1(1)和[Cu(L2)2(NO3)2(H2O)](2),其中L1为3,6-二(苯并三唑-1-)哒嗪,L3为3-(1,2,4-三氮唑-1-)-6-氯哒嗪.配合物1的晶体属于三斜晶系,P1-空间群.铜离子与3个氯原子和配体的2个氮原子形成五配位的四角锥构型,2个氯原子以μ-2方式桥联2个中心铜原子.在配合物1的晶胞中1个游离配体未参与配位.配合物2的晶体属于单斜晶系,C2/c空间群.铜原子处于五配位四角锥配位环境中.分子间氢键将2的分子结构延伸为一维链、二维网状结构.并通过分子间的π-π堆积作用进一步使配合物构型发展成三维拓扑结构.应用邻苯三酚自氧化法对本文所涉及的化合物进行了清除自由基活性测试,结果表明:这2个配体都具有较好的活性.     

含水杨醛缩对硝基苯甲酰腙的钒酰配合物和钴配合物的合成和晶体结构

本文合成了含水杨醛缩对硝基苯甲酰腙(简写为H2L)的钒酰配合物VOL(CH3OH)(CH3O)(1,C16H16N3O7V,Mr=413.26)和钴配合物[CoL(C5H5N)3]NO3C5H5N(2,C34H29N8O7Co,Mr=720.58)。配合物1属单斜晶系,空间群为P21/c,a=7.3253(3),b=18.8237(9),c=12.9014(5)?b=91.672(1),V=1778.2(1)3,Z=4,F(000)=848,m(MoKa)=0.603mm1,R=0.0470,wR=0.1312。配合物2属单斜晶系,空间群为P21/c,a=11.4196(8),b=17.157(1),c=17.081(1)?b=96.8233(9),V=3323.0(4)3,Z=4,F(000)=1488,m(MoKa)=0.578mm1,R=0.0455,wR=0.1311。在配合物1中,钒(V)原子由周围的酰氧基原子、配体L2的3个配位原子,去质子化甲醇的甲氧基原子和配位甲醇的氧原子配位,形成畸变的VO(ONO)(O)(O)八面体配位构型。晶体内每2个分子间通过氢键作用缔合成中心对称的分子对,OH…N氢键键长为2.861(4)?键角163.20。晶体中存在着弱p-p共轭作用。在配合物2中,钴(Ⅲ)原子由1个L2的3个配位原子和3个配位吡啶分子的3个氮原子配位,呈N4O2八面体配位构型。     

Preparation and structural characterization of oxovanadium(V) complexes with Schiff bases and their inhibition studies on Helicobacter pylori urease

A series of structurally similar dinuclear oxovanadium(V) complexes, [VO₂L]₂ (L?=?L¹?=?2-[(2-methylaminoethylimino)methyl]phenolate (1); L?=?L²?=?2-[(2-ethylaminoethylimino)methyl]phenolate (2); L?=?L³?=?2-[(2-isopropylaminoethylimino)methyl]phenolate (3)), has been synthesized and characterized by physico-chemical methods and single-crystal X-ray diffraction. The V in each complex is octahedral, with three donors of L and one oxo defining the equatorial plane, and with two oxos occupying the axial positions. The complexes were tested for their urease inhibitory activities. The inhibition rate (%) of 1, 2, and 3 at 100?µmol?L^?1 on urease are 67?±?1, 53.5?±?0.9, and 44?±?1. The relationship between structures of the complexes and the urease inhibitory activities indicates that shorter terminal groups of the complexes have stronger activities against urease. Molecular docking study of the complexes with the Helicobacter pylori urease was performed.     

Syntheses and crystal structures of two Schiff-base copper(II) complexes with urease inhibition

Two new copper(II) complexes, [CuL1(N₃)] (1) and [CuL2(NCS)] (2) (HL1 = 4-chloro-2-[(2-piperidin-1-ylethylimino)methyl]phenol, HL2 = 4-chloro-2-[(2-morpholin-4-ylethylimino)methyl]phenol), were prepared and structurally characterized by elemental analyses, infrared spectroscopy, and single-crystal X-ray diffraction. Complex 1 is an azide coordinated mononuclear complex, while complex 2 is a terminal thiocyanate coordinated mononuclear complex. The coppers in both complexes are four-coordinate, square-planar. Both complexes show potent urease inhibitory properties.     

Synthesis,crystal structures and Jack bean urease inhibitory activity of copper(II) complexes with 4-bromo-N′-(2-hydroxy-5-methoxybenzylidene)benzohydrazide

A new hydrazone 4-bromo-N′-(2-hydroxy-5-methoxybenzylidene)benzohydrazide (HL) was prepared and characterized by infrared and UV–vis spectra, as well as single-crystal X-ray diffraction. With the hydrazone as ligand, two new copper(II) complexes were prepared, [Cu₂L₂(NCS)₂]·4H₂O (1) and [CuBrL]·CH₃OH (2). The complexes were characterized by infrared and UV–vis spectra, and single-crystal X-ray diffraction. The Cu in 1 is in a square pyramidal coordination geometry and that in 2 is in a square planar coordination geometry. The two complexes show effective Jack bean urease inhibitory activity, with IC₅₀ values of 23.5 and 2.7 μM, respectively. A molecular docking study of 2 with the urease was performed. The relationship between the structure and urease inhibitory activity indicated that copper complex with square planar coordination is a better model for urease inhibition.     

Synthesis,structures, and urease inhibition of nickel(II), zinc(II), and cobalt(II) complexes with similar hydroxy-rich Schiff bases

Four new nickel(II), zinc(II), and cobalt(II) complexes, [Zn(L¹)₂]?·?H₂O (1), [Ni(L¹)₂]?·?H₂O (2), [Ni(L²)₂] (3), and [Co(L³)₂]?·?H₂O (4), derived from hydroxy-rich Schiff bases 2-{[1-(5-chloro-2-hydroxyphenyl)methylidene]amino}-2-methylpropane-1,3-diol (HL¹), 2-{[1-(2-hydroxy-3-methoxyphenyl)methylidene]amino}-2-ethylpropane-1,3-diol (HL²), and 2-{[1-(5-bromo-2-hydroxyphenyl)methylidene]amino}-2-methylpropane-1,3-diol (HL³) have been synthesized and characterized by elemental analyses, infrared spectroscopy, and single-crystal X-ray determination. Each metal in the complexes is six-coordinate in a distorted octahedral coordination. The Schiff bases coordinate to the metal atoms through the imino N, phenolate O, and one hydroxyl O. In the crystal structures of HL¹ and the complexes, molecules are linked through intermolecular O–H···O hydrogen bonds, forming 1-D chains. The urease inhibitory activities of the compounds were evaluated and molecular docking study of the compounds with the Helicobacter pylori urease was performed.     

New [LNiII2]+ complexes incorporating 2-formyl or 2,6-diformyl-4-methyl phenol as inhibitors of the hydrolysis of the ligand L3-: Ni...Ni ferromagnetic coupling and S=2 ground states

Reaction of the dinucleating ligand H3L (2-(2'-hydroxyphenyl)-1,3-bis[4-(2-hydroxyphenyl)-3-azabut-3-enyl]-1,3-imidazolidine) with Ni(NO3)(2).6H2O produces the dimer of monomers [Ni(HL1)]2(NO3)(2).4H2O (1.4H2O) following the hydrolysis of H3L. If the reaction occurs in the presence of 2-formylphenol (Hfp) or 2,6-diformyl-4-methylphenol (Hdfp), this hydrolysis is prevented by incorporation of these co-ligands into the structure and stabilization of the new complexes [Ni2L(fp)(H2O)].3H2O (2.3H2O) and [Ni2L(dfp)].4.5H2O (3.4.5H2O), respectively. Complexes 2 and 3 may be considered to be structural models of the active site of urease, where coordination of the carbonyl ligand mimics binding of urea. In complex 2, coordination of terminal water reproduces the binding of this substrate of the enzyme to the active site. In both dinuclear complexes, the NiII ions are coupled ferromagnetically to yield S=2 ground states, whereas complex 1 exhibits weak intradimer antiferromagnetic exchange through hydrogen bonds. The magnetic data can be modeled by using the Van Vleck equation, incorporating intermolecular interactions, or by diagonalization of a spin Hamiltonian that includes single-ion anisotropy.     

Varying coordination modes and magnetic properties of copper(II) complexes with diazamesocyclic ligands by altering additional donor pendants on 1,5-diazacyclooctane

A series of new diazamesocyclic ligands based on a diazamesocycle, 1,5-diazacyclooctane (DACO), functionalized by additional donor groups--1,5-bis(N-1-methylimidazol-2-ylmethyl)-1,5- diazacyclooctane (L1), 1-(2-hydroxybenzyl)-1,5-diazacyclooctane (HL2), 1,5-bis(2-hydroxybenzyl)-1,5-diazacyclooctane (H2L3), and 1-(N-1-methylimidazol-2-ylmethyl)-1,5-diazacyclooctane (L4)--and their Cu(II) complexes have been synthesized and characterized. Single-crystal X-ray diffraction analysis of the four Cu(II) complexes revealed that L1 forms a five-coordinate mononuclear complex, HL2 a N3- mu-bridged binuclear complex, H2L3 an oxygen mu-bridged trinuclear complex, and L4 a one-dimensional zigzag coordination polymeric complex with Cu(II). [CuL1ClO4](ClO4) (I): a = 12.194(2) A, b = 13.351(3) A, c = 14.473(3) A, beta = 107.10(3) degrees, Z = 4. [CuL2(N3)]2 (II): a = 8.1864(6) A, b = 18.141(2) A, c = 9.3307(7) A, beta = 103.662(6) degrees, Z = 2. [Cu3(L3)2Cl2] (III): a = 10.7296(13) A, b = 13.7707(17) A, c = 13.5523(17) A, beta = 106.350(3) degrees, Z = 2. ([CuL4Cl]2ClO4) infinity (IV): a = 7.279(1) A, b = 23.695(5) A, c = 19.308(4) A, beta = 100.28(3) degrees, Z = 8. All four complexes crystallize in the monoclinic crystal system with the P2(1)/c space group, and each Cu(II) center coordinated with DACO is pentacoordinated with a distorted square-pyramidal or trigonal-bipyrimidal coordination environment. In complex IV, the binuclear cation unit [CuL4Cl]2(2+) constitutes the fundamental building block of an infinite alternating zigzag chain structure, and the binuclear unit contains two types of geometries around the Cu(II) centers: the Cu(1) center is a distorted square-pyramidal environment, while the Cu(2) is a distorted trigonal-bipyramidal coordination environment. To the best of our knowledge, this is the first Cu(II) complex of a diazamesocyclic ligand with an infinite polymeric structure. The magnetic properties of complexes II, III, and IV have been investigated by variable-temperature magnetic susceptibility measurements in the solid state. The obtained parameters are 2J = 2.06 cm-1 (II), -345.56 cm-1 (III), and -2.60 cm-1 (IV), which differ greatly from ferromagnetic to weak and strong antiferromagnetic coupling. These results unequivocally indicate that the nature of the pendant arms is a key factor governing the structure and properties of the complexes; therefore, the coordination modes and properties of the metal complexes of a diazamesocycle can be controlled by altering the pendant donors on it. Magneto-structural correlation has been precisely analyzed, and the solution properties of these complexes have also been described.     

Novel linear transition metal clusters of a heptadentate bis-beta-diketone ligand

The synthesis and the structure of the new potentially heptadentate ligand 1,3-bis-(3-oxo-3-(2-hydroxyphenyl)-propionyl)-2-methoxybenzene (H5L) is described. The reaction in pyridine or DMF of this ligand with various M(AcO)2 salts (M = NiII, CoII, MnII) leads to very different products depending on the metal. Thus, the dinuclear complexes [M2(H3L)2(py)4] (M = NiII, 1; CoII, 2) or the linear zigzag tetranuclear clusters [Mn4(H2L)2(AcO)2(py)5] (3) and [Mn4(H2L)2(AcO)2(dmf)4] (4) have been synthesized and characterized crystallographically. Slow oxidation of complex 3 leads to the formation of the novel mixed-valence linear complex [Mn3(HL)2(py)6] (5), displaying an unprecedented asymmetric MnIIIMnIIIMnII topology. The coordination geometry of complexes 1 to 5 has been analyzed and discussed by means of continuous shape measures. Magnetic measurements of 3 and 5 demonstrate that the metals within these complexes weakly interact magnetically with coupling constants of J1 = -1.13 cm-1 and J2 = -0.43 cm-1 (S = 0) for complex 3 and J1 = -5.4 cm-1 and J2 = -0.4 cm-1 (S = 5/2) for complex 5 (using the H = -Sigma2JijSiSj convention). These results are consistent with X-band EPR measurements on these compounds.     

EXAFS study of aqueous Zr(IV) and Th(IV) complexes in alkaline CaCl(2) solutions: Ca(3)[Zr(OH)(6)](4+) and Ca(4)[Th(OH)(8)](4+)

A hitherto unknown type of aqueous complex, ternary Ca-MIV-OH complexes (M = Zr and Th), causes unexpectedly high solubilities of zirconium(IV) and thorium(IV) hydrous oxides in alkaline CaCl2 solutions (pHc = 10-12, [CaCl2] > 0.05 mol.L(-1), and pHc = 11-12, [CaCl2] > 0.5 mol.L(-1), respectively). The dominant aqueous species are identified as Ca3[Zr(OH)6]4+ and Ca4[Th(OH)8]4+ and characterized by extended X-ray absorption fine structure (EXAFS) spectroscopy. The number of OH- ligands in the first coordination sphere detected by EXAFS, NO = 6 (6.6 +/- 1.2) for Zr and NO = 8 (8.6 +/- 1.2) for Th, are consistent with the observed slopes of 2 and 4 in the solubility curves log [M]tot vs pHc. The presence of polynuclear hydrolysis species and the formation of chloride complexes can be excluded. EXAFS spectra clearly show a second coordination shell of calcium ions. The [Zr(OH)6]2- and [Th(OH)8]4- complexes with an unusually large number of OH- ligands are stabilized by the formation of associates or ion pairs with Ca2+ ions. The number of neighboring Ca2+ ions around the [Zr(OH)6]2- and [Th(OH)8]4- units is determined to be NCa = 3 (2.7 +/- 0.6) at a distance of RZr-Ca = 3.38 +/- 0.02 A and NCa = 4 (3.8 +/- 0.5) at a distance of RTh-Ca = 3.98 +/- 0.02 A. The Ca3[Zr(OH)6]4+ and Ca4[Th(OH)8]4+ complexes have first (M-O) and second (M-Ca) coordination spheres with the Ca2+ ions bound to coordination polyhedra edges.